-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on BioNTech, Raises Price Target to $93

Benzinga·11/19/2026 18:57:58
Listen to the news
JP Morgan analyst Jessica Fye maintains BioNTech (NASDAQ:BNTX) with a Neutral and raises the price target from $92 to $93.